ArticleCureus2026
Molecular Detection of Gastrointestinal Pathogens Using a Multiplex Gastrointestinal Panel and Their Associations With Demographic and Clinical Characteristics.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Acute gastroenteritis causes morbidity across all age groups, and timely, effective identification of its etiologic agents is essential for clinical management and antimicrobial stewardship. Conventional diagnostic methods have limited sensitivity and often fail to detect coinfections or specific bacterial pathotypes. In contrast, molecular methods, such as FilmArray panels, are rapid, highly sensitive, and capable of detecting coinfections. This study aimed to characterize gastrointestinal pathogens detected by the BioFire FilmArray Gastrointestinal Panel (BioFire Diagnostics, LLC, Salt Lake City, UT, USA; a bioMérieux company) and to evaluate their association with demographic and clinical characteristics among patients at Hospital Angeles Lindavista, Mexico City, Mexico. Methods A retrospective observational study conducted from January 2022 to July 2025 included all patients who underwent gastrointestinal molecular testing. Demographic data, clinical characteristics, and multiplex PCR results were extracted from electronic medical records and the FilmArray database. Data were analyzed using descriptive statistics, logistic regression, Fisher's exact test, and Spearman correlation. Results An analysis of 1,120 samples found an overall positivity rate of 906 (81%). Coinfections were present in 543 (49%) cases. The most common pathogens were enteropathogenic
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.